David Lebwohl Sells $116K of Intellia Therapeutics Inc (NTLA) — SEC Form 4, Jan 07, 2025

Open-Market Net Sale · SEC Form 4

−$116,404

Equity position changed by -9.8%

Reporting Owner

David Lebwohl

EVP

TXN 2025-01-03 · FILED 2025-01-07

Equity Position 87.7K sh 97,223 → 87,666

Equity Change -9.8% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Intellia Therapeutics Inc

NTLA CIK 0001652130

Reporting Owner

Name	Relationship
David Lebwohl CIK 0001810882	EVP

David Lebwohl at Intellia Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $109,627

More from this insider at Intellia Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2025-01-03	S - Sale	9,557 D	$12.18	-$116,404	87,666	Direct

Footnotes (1)

F1: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Intellia Therapeutics Inc

GET /v1/forms/4/0000950170-25-003015 API docs